1. Home
  2. GTIM vs HOTH Comparison

GTIM vs HOTH Comparison

Compare GTIM & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.20

Market Cap

13.7M

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTIM
HOTH
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
15.8M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
GTIM
HOTH
Price
$1.20
$1.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
43.4K
403.0K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$142,315,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$60.50
N/A
Revenue Growth
3.01
N/A
52 Week Low
$1.10
$0.66
52 Week High
$2.65
$2.12

Technical Indicators

Market Signals
Indicator
GTIM
HOTH
Relative Strength Index (RSI) N/A 51.18
Support Level N/A $0.78
Resistance Level N/A $1.13
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.02
Stochastic Oscillator 0.00 69.92

Price Performance

Historical Comparison
GTIM
HOTH

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: